Mallinckrodt plc Stock Price and Value Analysis

Should you buy Mallinckrodt plc stock? (NYSE:MNK). Let's see how it does in our automated value investing analysis system.

MNK Free Cash Flow Trend

Free Cash Flow trendline for MNK
Free Cash Flow trendline for Mallinckrodt plc

Hmm, we can't give any reliable projection for Mallinckrodt plc's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

  • This company is not making money.
  • This company is less known than others.
  • This company has wild ups and downs.
  • This stock looks overpriced.
  • This company pays no dividend.

Inside the MNK Numbers

MNK Price
(Mallinckrodt plc stock price per share)
[?] PE Ratio versus Sector 94% lower than other Healthcare stocks
[?] PE Ratio versus Industry 98% lower than other Drug Manufacturers - Specialty & Generic stocks
[?] Cash Yield -5.45%
[?] Free Cash Flow Jitter 145%

Is Mallinckrodt plc Stock on Sale?

Based on our analysis, we believe that you should not buy Mallinckrodt plc right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy MNK Stock?

Does Mallinckrodt plc have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.